Detection and Identification of Hematologic Malignancies and Solid Tumors by an Electrochemical Technique

Abstract

PurposeDevelop and evaluate an electrochemical method to identify healthy individuals, malignant hematopathic patients and solid tumor patients by detecting the leukocytes in whole-blood.MethodsA total of 114 individual blood samples obtained from our affiliated hospital in China (June 2015- August 2015) were divided into three groups: healthy individuals (n = 35), hematologic malignancies (n = 41) and solid tumors (n = 38). An electrochemical workstation system was used to measure differential pulse voltammetry due to the different electrochemical behaviors of leukocytes in blood samples. Then, one-way analysis of variance (ANOVA) was applied to analyze the scanning curves and to compare the peak potential and peak current.ResultsThe scanning curve demonstrated the specific electrochemical behaviors of the blank potassium ferricyanide solution and that mixed with blood samples in different groups. Significant differences in mean peak potentials of mixture and shifts (ΔEp (mV)) were observed of the three groups (P< = 0.001). 106.00±9.00 and 3.14±7.48 for Group healthy individuals, 120.90±11.18 and 18.10±8.81 for Group hematologic malignancies, 136.84±11.53 and 32.89±10.50 for Group solid tumors, respectively. In contrast, there were no significant differences in the peak currents and shifts.ConclusionsThe newly developed method to apply the electrochemical workstation system to identify hematologic malignancies and solid tumors with good sensitivity and specificity might be effective, suggesting a potential utility in clinical application.

Artificial Intelligence based Models for Screening of Hematologic Malignancies using Cell Population Data

“…Clinical and biological classifications have been developed by the World Health Organization (WHO) to recognize, categorize and treat the hematological malignancies 5 . Various clinical methods and techniques, such as biopsies, blood tests, immunology tests, flow cytometry, radiology exams, as well as genetics technologies, such as chromosome analysis and DNA sequencing exist for the diagnosis of hematological malignancies 6,7 . Complete Blood Count (CBC) is one of the basic and fundamental tests to evaluate a variety of health disorders including hematological malignancies.…”

Clinical and Experimental Substantiation of The Use of Macrolide Antibiotic in Gastrointestinal and Respiratory Diseases

“…To study the physiological and biochemical changes in the body of laboratory animals before stress exposure and after 1, 10, 15, 30, 35, and 60 days, blood was taken from blood vessels, in which the content of erythrocytes and leukocytes was examined on the Culter Count particle counter (France), hemoglobin -Sali hemometer and hemoglobin cyanide method, hematocrit on a spiral MPV-310 centrifuge (Poland), SOE -according to Panchenkov, leukogram -by counting 200 cells stained according to Romanovsky-Giemsa, with the calculation of the percentage of each species [15][16][17]. Antimicrobial activity of the drug against reference strains of mycoplasmas and acholeplasmas, as well as field cultures of Escherichia, Pasteurella, and Staphylococcus aureus, were studied on liquid and dense nutrient media using the 2,3,5triphenyltetrazolium chloride indicator with the determination of bactericidal and bacteriostatic effects of the drugs [18].…”

Haematological malignancies implications during the times of the COVID‑19 pandemic (Review)

“…The diagnosis of these types of cancer is quite complex and achieved through histology, cytology, cytogenetics, immunophenotype and imaging (40). These methods exhibit high cost and complexity while also being highly time-consuming (41). Furthermore, patients themselves might complicate diagnosis based on their ability to understand their symptoms and react accordingly (42).…”